Shepherd Financial Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Shepherd Financial Partners's GILD Position: Q2 2026 in Review
Shepherd Financial Partners increased its Gilead Sciences (GILD) stake by 0.95% in Q2 2026, buying an estimated $3.95K and bringing the position to 3,173 shares worth $401K. The position accounts for 0.03% of the portfolio, ranked #184.
Shepherd Financial Partners first reported a position in GILD in Q4 2016 and has held it in 20 quarters since. The position peaked at $447K in Q4 2016. 2,279 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Shepherd Financial Partners held 3,173 shares of Gilead Sciences worth $401K as of Q2 2026.
- Shepherd Financial Partners bought 30 Gilead Sciences shares in Q2 2026, an estimated $3.95K.
- Gilead Sciences made up 0.03% of Shepherd Financial Partners's portfolio in Q2 2026, its #184 holding.
- Shepherd Financial Partners first reported a position in Gilead Sciences in Q4 2016 and has held it in 20 quarters since.
- Shepherd Financial Partners's Gilead Sciences position peaked at $447K in Q4 2016.
- 2,279 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Shepherd Financial Partners's 13F filing for Q2 2026, filed 10 Aug 2026.